SARTORIUS AG UNSP.ADR 1/5 Cash Flow Conversion Efficiency

Latest as of March 2026: 0.049x

SARTORIUS AG UNSP.ADR 1/5 cash flow conversion efficiency. Based on the latest financial reports, SARTORIUS AG UNSP.ADR 1/5 (SRT4) has a cash flow conversion efficiency ratio of 0.049x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€188.90 Million ≈ $220.84 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SRT4 company net worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of SARTORIUS AG UNSP.ADR 1/5 (2021–2025)

Cash flow conversion efficiency of SARTORIUS AG UNSP.ADR 1/5 from 2021 to 2025. This chart illustrates how SARTORIUS AG UNSP.ADR 1/5's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SRT4 share price today for real-time trading data and today's change.

SARTORIUS AG UNSP.ADR 1/5 Cash Flow Conversion Ratio Explained

SARTORIUS AG UNSP.ADR 1/5 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SARTORIUS AG UNSP.ADR 1/5 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SARTORIUS AG UNSP.ADR 1/5 ranked by their cash flow conversion efficiency. Review SARTORIUS AG UNSP.ADR 1/5 (SRT4) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
PSP SWISS ADR 1/5/SF1050
F:P7S0
0.011x
Fibra UNO
MX:FUNO11
0.011x
TPG Inc
NASDAQ:TPG
0.093x
Ralliant Corporation Common Stock
NYSE:RAL
0.012x
Venture Global, Inc.
NYSE:VG
0.062x
SPIE SA
PA:SPIE
0.080x
Alexandria Real Estate Equities Inc
NYSE:ARE
0.010x
Inventec Corp
TW:2356
0.239x

Annual Cash Flow Conversion Efficiency for SARTORIUS AG UNSP.ADR 1/5 (2021–2025)

The table below shows the annual cash flow conversion efficiency of SARTORIUS AG UNSP.ADR 1/5 from 2021 to 2025. Also see SARTORIUS AG UNSP.ADR 1/5 balance sheet assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €3.87 Billion
≈ $4.52 Billion
€837.00 Million
≈ $978.54 Million
0.216x -13.58%
2024-12-31 €3.90 Billion
≈ $4.56 Billion
€976.20 Million
≈ $1.14 Billion
0.250x -19.08%
2023-12-31 €2.76 Billion
≈ $3.22 Billion
€853.60 Million
≈ $997.95 Million
0.309x +12.09%
2022-12-31 €2.66 Billion
≈ $3.11 Billion
€734.20 Million
≈ $858.36 Million
0.276x -45.60%
2021-12-31 €1.72 Billion
≈ $2.01 Billion
€873.20 Million
≈ $1.02 Billion
0.508x --

About SARTORIUS AG UNSP.ADR 1/5

F:SRT4 Germany Medical Instruments & Supplies
Market Cap
$7.12 Billion
€6.09 Billion EUR
Market Cap Rank
#2757 Global
#558 in Germany
Share Price
€35.60
Change (1 day)
-3.78%
52-Week Range
€29.20 - €40.20
All Time High
€171.85
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more